Literature DB >> 20578072

High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.

Takashi Ibe1, Kimihiro Shimizu, Tetsuhiro Nakano, Seiichi Kakegawa, Mitsuhiro Kamiyoshihara, Takashi Nakajima, Kyoichi Kaira, Izumi Takeyoshi.   

Abstract

BACKGROUND: Thymidylate synthase (TS) expression has been reported in various tumors, including non-small-cell lung carcinoma (NSCLC), but not in high-grade neuroendocrine (HGNE) carcinoma of the lung.
METHODS: We measured TS expression in surgically resected pulmonary tumors, comparing HGNE carcinomas of the lung (13 large-cell neuroendocrine carcinomas, 8 small-cell lung carcinomas) with squamous cell carcinoma and adenocarcinoma of the lung using laser-capture microdissection for tissue isolation, real-time polymerase chain reaction (PCR), and immunohistochemistry. We also measured TS mRNA expression in small-cell lung carcinoma (SCLC) and NSCLC cell lines using real-time PCR.
RESULTS: At both mRNA and protein levels, TS expression was significantly higher in squamous cell carcinoma compared to adenocarcinoma. Moreover, TS expression was significantly higher in HGNE carcinomas of the lung compared to squamous cell carcinoma. A significant correlation was found between mRNA and protein expression. TS mRNA expression in SCLC cell lines was significantly higher than in NSCLC cell lines.
CONCLUSIONS: TS expression was higher in HGNE carcinomas of the lung than in squamous cell carcinoma, which was higher than in adenocarcinoma. This information may be useful in predicting the effects of TS-inhibiting agents in patients with NSCLC and HGNE carcinomas of the lung. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578072     DOI: 10.1002/jso.21576

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Chemotherapy advances in small-cell lung cancer.

Authors:  Bryan A Chan; Jermaine I G Coward
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.

Authors:  Kyoichi Kaira; Yasuhisa Ohde; Kazuo Nakagawa; Takehiro Okumura; Haruyasu Murakami; Toshiaki Takahashi; Haruhiko Kondo; Takashi Nakajima; Masahiro Endo; Nobuyuki Yamamoto
Journal:  Med Oncol       Date:  2011-09-24       Impact factor: 3.064

3.  Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed.

Authors:  Lachelle D Weeks; Pingfu Fu; Stanton L Gerson
Journal:  Mol Cancer Ther       Date:  2013-07-19       Impact factor: 6.261

4.  A phase II study of S-1 in relapsed small cell lung cancer.

Authors:  Keita Kudo; Fumiyosi Ohyanagi; Atsushi Horiike; Eisaku Miyauchi; Hisashi Tahanaka; Noriko Yanagitani; Ryouta Saito; Kyouhei Kaburaki; Toshio Sakatani; Takeshi Horai; Makoto Nishio
Journal:  Mol Clin Oncol       Date:  2013-01-14

5.  Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancer.

Authors:  Madoka Kimura; Fumio Imamura; Takako Inoue; Kazumi Nishino; Junji Uchida; Toru Kumagai; Jiro Okami; Masahiko Higasiyama; Shingo Kamoshida
Journal:  Mol Clin Oncol       Date:  2017-05-16

Review 6.  Morphologic and molecular classification of lung neuroendocrine neoplasms.

Authors:  Jasna Metovic; Giuseppe Pelosi; Marco Barella; Fabrizio Bianchi; Paul Hofman; Veronique Hofman; Myriam Remmelink; Izidor Kern; Lina Carvalho; Linda Pattini; Angelica Sonzogni; Giulia Veronesi; Sergio Harari; Fabien Forest; Mauro Papotti
Journal:  Virchows Arch       Date:  2021-01-21       Impact factor: 4.064

7.  Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.

Authors:  Yoichi Ohtaki; Kyoichi Kaira; Toshiki Yajima; Bilguun Erkhem-Ochir; Osamu Kawashima; Mitsuhiro Kamiyoshihara; Hitoshi Igai; Ryoichi Onozato; Takashi Ibe; Takayuki Kosaka; Seshiru Nakazawa; Toshiteru Nagashima; Tetsunari Oyama; Ken Shirabe
Journal:  Thorac Cancer       Date:  2021-08-28       Impact factor: 3.500

Review 8.  The pemetrexed-containing treatments in the non-small cell lung cancer is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis.

Authors:  Lei Wang; Rui Wang; Yunjian Pan; Yihua Sun; Jie Zhang; Haiquan Chen
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

9.  Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.

Authors:  William H Gmeiner; Lance D Miller; Jeff W Chou; Anthony Dominijanni; Lysette Mutkus; Frank Marini; Jimmy Ruiz; Travis Dotson; Karl W Thomas; Graham Parks; Christina R Bellinger
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.